BackXbrane Biopharma AB (publ) Overview

Xbrane Biopharma AB (publ) Inventory

Xbrane Biopharma AB (publ)'s inventory is $150M.

Get informed when a big investor buys or sells

+ Follow
Inventory
$149.40M
↓ 25.94% YoYΔ $-52.32M vs prior year quarter

Peer trimmed avg / median

Loading

Xbrane Biopharma AB (publ) Inventory History

Loading

Xbrane Biopharma AB (publ) vs. peers: Inventory Comparison

Loading

Xbrane Biopharma AB (publ) Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Xbrane Biopharma AB (publ) (XBRANE.ST) FAQ

Xbrane Biopharma AB (publ)'s inventory stands at $150M as of September 2026. That compares with $200M in the prior-year period — down 25.9% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Xbrane Biopharma AB (publ) reported $150M in inventory versus $200M a year earlier — a 25.9% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $200M in the prior-year period — down 25.9% year over year. Sustained growth in inventory can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Xbrane Biopharma AB (publ)'s inventory evolved across reporting periods, while the comparison chart places XBRANE.ST next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, inventory is commonly used to spot outliers. Xbrane Biopharma AB (publ)'s reading of $150M is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.